The Liverpool Cancer Research Institute (LCRI), builds on the success of previous strategic cancer research initiatives in the region, and aims to further consolidate the existing strengths in biomedical and translational cancer research in Liverpool, grow its capability and accelerate the translation of research into improved patient outcomes. At the heart of the endeavour is a three-way partnership between the region’s three biggest stakeholders in cancer research, namely the University of Liverpool (UoL), The Clatterbridge Cancer Centre NHS Foundation Trust (CCC) and North West Cancer Research (NWCR), working alongside Liverpool Health Partners.

The application deadline is now closed.

The final deadline for submission was January 17th 2022. Applications will be reviewed and evaluated on a competitive basis by the LCRI Leadership Team and other PIs within the University of Liverpool.

More general information regarding the grant application process can be found on this document, LCRI RDF Grant Overall Info.

You can find the application form to apply here, LCRI RDF Application Form 2021.

To find out more about the scoring system, please check here LCRI RDF 21 Scoring System.

The below terms of reference are to aid submission of proposals:

  • Funding is available to LCRI teams of researchers from all disciplines and Faculties within the University of Liverpool and clinicians working at the and NHS organisations represented through Liverpool Health Partners.
  • Proposals for collaborative projects between multidisciplinary research groups which have not previously worked together are strongly encouraged.
  • Cross-disciplinary (e.g. all Faculties of UoL) Research projects that align with the four cross-cutting research themes of LCRI are strongly encouraged. The themes are:
    • Early cancer diagnosis
    • Molecular mechanisms of cancer progression
    • Tumour microenvironment and immuno-oncology
    • Cancer pharmacology and therapy failure
  • Any sum can be requested up to a maximum of £60,000 but the LCRI Leadership Team are likely to make several grants within the total funding envelope. The average award made under similar schemes and the auspices of NWCRC in the past is ~£11K. Note that funds must be spent within 12 months of the project award date.
  • The most important quality that the panel will be looking for is outstanding cancer research by teams of researchers based at the University and clinicians based in the LHP NHS Trusts in the form of new pilot projects, which have a strong potential to lead to project and/or programme grants. However, applications which seek to consider the effectiveness of treatments and develop new techniques for these are also encouraged.
  • All projects should reference cancer types and / or treatments which are relevant to the people of the Merseyside area.
  • Applications led by Early Career Researchers are strongly encouraged.
  • Proposals for matched funding for access to-, use of- and/or purchase of- multiuser equipment will be considered.
  • Proposals for travel assistance and short research placements as part of developing programme grant proposals for clearly identified calls within the next 6-12 months of the award to consolidate collaborations and KE between laboratories will be considered.
  • Researchers and clinicians who have had RDF funding from LCRI partner organisations within the last 24 months will not be eligible to apply.

This RDF call is funded by NWCR as part of the LCRI partnership. Please contact Dr Matina Tsalavouta on if you have any questions about this funding scheme and return all submissions via email by the deadline to

Back to: Liverpool Cancer Research Institute